Published in
Springer Verlag, Modern Rheumatology, p. 1-13
DOI: 10.1080/14397595.2018.1484269
Links
Tools
ABBV-105, a selective and irreversible inhibitor of Bruton’s tyrosine kinase, is efficacious in multiple preclinical models of inflammation
Journal article published in 2018 by
Christian Goess 
,
Christopher M. Harris,
Sara Murdock,
Richard W. McCarthy,
Erik Sampson,
Rachel Twomey,
Suzanne Mathieu,
Regina Mario,
Matthew Perham,
Eric R. Goedken,
Andrew J. Long
,
Christopher M. Harris,
Sara Murdock,
Richard W. McCarthy,
Erik Sampson,
Rachel Twomey,
Suzanne Mathieu,
Regina Mario,
Matthew Perham,
Eric R. Goedken,
Andrew J. Long
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
